The African Programme for Onchocerciasis Control: impact on onchocercal skin disease
暂无分享,去创建一个
M. Murdoch | M. Boussinesq | A. Bissek | M. Noma | A. Sékétéli | U. Amazigo | M. Hagan | K. Ogbuagu | G. Ozoh | M. Shamad | E. Braide | I. Murdoch
[1] J. Okeibunor,et al. Where would I be without ivermectin? Capturing the benefits of community‐directed treatment with ivermectin in Africa , 2011, Tropical medicine & international health : TM & IH.
[2] Daniel Pilger,et al. Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial. , 2010, Bulletin of the World Health Organization.
[3] African Programme for Onchocerciasis Control - report of the sixth meeting of National Task Forces, October 2009. , 2010, Releve epidemiologique hebdomadaire.
[4] L. Konaté,et al. Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal , 2009, PLoS neglected tropical diseases.
[5] U. Amazigo. The African Programme for Onchocerciasis Control (APOC) , 2008, Annals of tropical medicine and parasitology.
[6] A. Onapa,et al. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues , 2008, Tropical medicine & international health : TM & IH.
[7] I. Dozie,et al. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south–eastern Nigeria , 2007, Annals of tropical medicine and parasitology.
[8] F. Richards,et al. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria. , 2004, The American journal of tropical medicine and hygiene.
[9] A. Hopkins,et al. The effect of 5 years of annual treatment with ivermectin (Mectizan®) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic , 2002, Annals of tropical medicine and parasitology.
[10] M. Murdoch,et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa , 2002, Annals of tropical medicine and parasitology.
[11] P. Enyong,et al. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC) , 2002, Annals of tropical medicine and parasitology.
[12] M. Strong,et al. Interventions for treating scabies. , 2007, The Cochrane database of systematic reviews.
[13] Ogbuagu,et al. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial , 1998, Tropical medicine & international health : TM & IH.
[14] B. Benton. Economic impact of onchocerciasis through the African Programme Onchocerciasis Control: control for an overview , 1998 .
[15] B. Benton. Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview. , 1998, Annals of tropical medicine and parasitology.
[16] E S Alley,et al. The impact of Mectizan on the transmission of onchocerciasis. , 1998, Annals of tropical medicine and parasitology.
[17] O. Oladepo,et al. Farm land size and onchocerciasis status of peasant farmers in south‐western Nigeria , 1997, Tropical medicine & international health : TM & IH.
[18] M. Downham,et al. Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis , 1996, Tropical medicine & international health : TM & IH.
[19] J. Whitworth,et al. Maintaining compliance to ivermectin in communities in two West African countries. , 1996, Health policy and planning.
[20] G. Burnham. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. , 1995, The American journal of tropical medicine and hygiene.
[21] P. Ngoumou,et al. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. , 1994, Annals of tropical medicine and parasitology.
[22] S. Cousens,et al. Ivermectin and onchocercal optic neuritis: Short-term effects , 1994, Eye.
[23] J. Evans,et al. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis , 1993, The Lancet.
[24] P. Enyong,et al. A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitologic findings after three treatments. , 1993, American Journal of Tropical Medicine and Hygiene.
[25] S. Diallo,et al. EFFICACY AND TOLERANCE OF IVERMECTININ HUMAN ONCHOCERCIASIS , 1982, The Lancet.
[26] S. Diallo,et al. Efficacy and tolerance of ivermectin in human onchocerciasis. , 1982, Lancet.
[27] S. G. Browne. Onchocercal depigmentation. , 1960, Transactions of the Royal Society of Tropical Medicine and Hygiene.